-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $56

Benzinga · 01/06/2023 09:01
Morgan Stanley analyst Cecilia Furlong maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target from $50 to $56.